| 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression L Ma, L Wang, AT Nelson, C Han, S He, MA Henn, K Menon, JJ Chen, ... Cancer Letters 493, 266-283, 2020 | 62 | 2020 |
| 3D microscopy and deep learning reveal the heterogeneity of crown-like structure microenvironments in intact adipose tissue J Geng, X Zhang, S Prabhu, SH Shahoei, ER Nelson, KS Swanson, ... Science Advances 7 (8), eabe2480, 2021 | 38 | 2021 |
| Nuclear receptors, cholesterol homeostasis and the immune system SH Shahoei, ER Nelson The Journal of steroid biochemistry and molecular biology 191, 105364, 2019 | 35 | 2019 |
| CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells I Benoit-Lizon, E Jacquin, TR Vargas, C Richard, A Roussey, L Dal Zuffo, ... Journal for immunotherapy of cancer 10 (1), 2022 | 29 | 2022 |
| Wnt5a influences viability, migration, adhesion, colony formation, E-and N-cadherin expression of human ovarian cancer cell line SKOV-3 F Jannesari-Ladani, G Hossein, N Monhasery, SH Shahoei, NI Mood Folia biologica 60 (2), 57, 2014 | 24 | 2014 |
| Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ H Deng, CJ Konopka, S Prabhu, S Sarkar, NG Medina, M Fayyaz, ... ACS nano 16 (2), 1999-2012, 2022 | 20 | 2022 |
| Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction S Prabhu, H Deng, TWL Cross, SH Shahoei, CJ Konopka, NG Medina, ... Biomaterials Science 9 (2), 506-518, 2021 | 15 | 2021 |
| Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors MJ Laws, Y Ziegler, SH Shahoei, P Dey, SH Kim, M Yasuda, BH Park, ... Breast cancer research and treatment 181 (2), 297-307, 2020 | 9 | 2020 |
| Small heterodimer partner regulates dichotomous T cell expansion by macrophages SH Shahoei, YC Kim, SJ Cler, L Ma, S Anakk, JK Kemper, ER Nelson Endocrinology 160 (7), 1573-1589, 2019 | 9 | 2019 |
| The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple-negative breast cancer AT Nelczyk, L Ma, AD Gupta, HEV Gamage, MT McHenry, MA Henn, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 166515, 2022 | 4 | 2022 |
| Vertical Integration of Cell‐Laden Hydrogels with Bioinspired Photonic Crystal Membranes Y Pei, SH Shahoei, Y Li, PJ Reece, ER Nelson, JJ Gooding, KA Kilian Advanced Materials Interfaces 5 (23), 1801233, 2018 | 3 | 2018 |
| OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy HE Vidana Gamage, SH Shahoei, S Albright, T Nguyen, RE Farmer, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2187, 2023 | | 2023 |
| NR0B2 re-educates myeloid cells within the tumor microenvironment: Potential novel strategy for breast cancer immunotherapy HEV Gamage, SH Shahoei, T Nguyen, R Farmer, S Albright, E Weisser, ... Cancer Research 83 (7_Supplement), 2358-2358, 2023 | | 2023 |
| Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression HEV Gamage, SH Shahoei, ST Albright, Y Wang, AJ Smith, R Farmer, ... bioRxiv, 2023.08. 14.553229, 2023 | | 2023 |
| Distinct tumor architectures for metastatic colonization of the brain S Gan, DG Macalinao, SH Shahoei, L Tian, X Jin, H Basnet, JT Muller, ... bioRxiv, 2023.01. 27.525190, 2023 | | 2023 |
| Functional Characterization of the Orphan Nuclear Receptor TLX in Triple Negative Breast Cancer A Nelson, Y Wang, L Ma, S He, M Henn, SH Shahoei, T Saleh, ... Journal of the Endocrine Society 5 (Supplement_1), A1019-A1019, 2021 | | 2021 |
| Abstract PR006: 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression L Ma, L Wang, AT Nelson, C Han, S He, MA Henn, K Menon, JJ Chen, ... Cancer Immunology Research 9 (2_Supplement), PR006-PR006, 2021 | | 2021 |
| The immunomodulatory roles of small heterodimer partner and their implications in breast cancer progression SH Shahoei University of Illinois at Urbana-Champaign, 2020 | | 2020 |
| OR05-01 Small Heterodimer Partner Modulates Antigen Presenting Myeloid Cells to Impair Regulatory T Cell Expansion, Promoting Anti-Tumor Immunity in Models of Breast Cancer SH Shahoei, AT Nelson, MA Henn, AE Mathews, JJ Chen, V Vembar, ... Journal of the Endocrine Society 4 (Supplement_1), OR05-01, 2020 | | 2020 |
| Macrophage-expressed small heterodimer partner impairs expansion of regulatory T cells and enhances immune checkpoint inhibition. SH Shahoei, AT Nelson, MA Henn, AE Mathews, JJ Chen, V Vembar, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 77-78, 2020 | | 2020 |
